Breast tomosynthesis: Dosimetry and image quality assessment on phantom

PurposeTo evaluate using phantom study the average glandular dose (AGD) and image quality in breast tomosynthesis.Materials and methodsThe study was performed with a full-field digital mammography system (Mammomat Inspiration®, Siemens, Erlangen, Germany) combined with tomosynthesis equipment (3D). For AGD evaluation, polymethyl methacrylate (PMMA) plates and a dosimeter were used to directly measure the absorbed doses in 2D and in 3D. The doses were then compared to the doses displayed on the equipment using the Mann–Whitney test. Three phantoms, accredited for 2D digital mammography (MTM 100, ACR RMI 156, BR3D), were imaged three times in 2D then in 3D. For each acquisition, the AGD was recorded. For image quality assessment, scores, defined by the rate of visible inserts, obtained for each acquisition both in 2D and in 3D, and for each phantom, were compared (Kruskall–Wallis and post-hoc Dunn tests).ResultsThere was no significant difference between the measured and displayed AGD, both in 2D and in 3D imaging (P > 0.05). With identical acquisition parameters, AGD were significantly greater in 3D than in 2D P < 0.01). For phantoms MTM 100 and ACR RMI 156, there was no significant difference between the rate of visible inserts in 2D and in 3D (P = 0.06 and P = 0.36, respectively). However for phantom BR3D, the rate was significantly higher in 3D than in 2D (P < 0.0001).ConclusionDoses are significantly greater in 3D than in 2D. With tomosynthesis, out of the three phantoms tested, only phantom BR3D showed a higher rate of visible inserts.